Endoscope Reprocessing Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Endoscope Reprocessing Market Dynamics

Technological Innovation in Reprocessing Capabilities Are Key Trend

• Technological advancement represents a transformative trend reshaping the endoscope reprocessing landscape.
• Modern automated endoscope reprocessors incorporate sophisticated features including closed-loop documentation systems, RFID tagging for device tracking, and cloud-based analytics platforms that capture comprehensive data on scope serial numbers, cycle parameters, and quality indicators.
• These innovations address historical challenges in maintaining consistent reprocessing standards while providing unprecedented transparency and traceability throughout the reprocessing workflow.
• The integration of artificial intelligence and machine learning algorithms enables predictive maintenance capabilities, identifying potential equipment failures before they compromise reprocessing efficacy.
• Advanced chemical formulations, including peracetic acid and hydrogen peroxide-based sterilants, offer superior microbial kill rates with shorter cycle times compared to traditional high-level disinfectants.
• Prominent players are actively launching AERs that are highly compatible with flexible endoscopes.
• Approximately 90% of the companies are developing AERs for flexible endoscopes due to their maneuverability and lower weight.
• The FDA regulates all the critical factors that must be assessed while reprocessing various endoscopes to mitigate the spread of infections.
• Additionally, as per the FDA guidelines, AER manufacturers must provide validation testing data.
• They also assist in detecting residual proteins, carbohydrates, and hemoglobin on both flexible and rigid endoscopes through the color comparison chart.
• Additionally, the development of single-use endoscope technologies for high-risk procedures represents a paradigm shift, eliminating reprocessing requirements entirely for specific applications while maintaining procedural efficacy and safety standards.

Rising Volume of Endoscopies and Infection Prevention Efforts Are Biggest Drivers

• The exponential growth in the volume of endoscopic procedures, coupled with the increasing number of healthcare facilities recognizing the risks of manual reprocessing, drives the endoscope reprocessing market.
• It is estimated that more than 20 million GI endoscopies are performed yearly in the U.S.
• The aging global population significantly contributes to this trend, as elderly individuals demonstrate higher susceptibility to gastrointestinal disorders, cancers, and other conditions requiring endoscopic intervention.
• According to the United Nations, the global population aged 60 and above will increase from 1.1 billion in 2023 to 1.4 billion by 2030, directly correlating with increasing endoscopic procedure requirements.
• The shift toward preventive healthcare and early disease detection further amplifies procedural volumes.
• Updated screening guidelines recommending earlier colonoscopy screening at age 45 in several countries have expanded the eligible population substantially.
• Public health investigations have identified concerns, including endoscope damage, mishandling, and reprocessing deficiencies, placing patients at risk for transmission of bacterial, viral, and other pathogens.
• High-profile outbreaks involving carbapenem-resistant Enterobacteriaceae (CRE) and other multidrug-resistant organisms have elevated infection prevention to the forefront of healthcare priorities, prompting substantial investments in advanced reprocessing technologies.
• Healthcare facilities increasingly recognize that manual reprocessing methods carry inherent risks of human error and variability.
• This recognition drives adoption of automated endoscope reprocessors that standardize cleaning cycles, integrate leak testing, and provide comprehensive documentation of every reprocessing step.
• The implementation of ATP bioluminescence testing, borescope inspections, and microbiological surveillance programs reflects the industry's commitment to validating cleaning efficacy.
• Furthermore, accreditation bodies and regulatory agencies mandate adherence to strict reprocessing protocols, with non-compliance potentially resulting in facility closures or significant financial penalties, thereby compelling healthcare providers to invest in state-of-the-art reprocessing solutions.

Endoscope Reprocessing Market Segmentation Analysis

Product Analysis

The high-level disinfectants & test strips category held the largest market share, of 35%, in 2024, due to the rising prevalence of various endogenous infections, such as pneumonia and bacteremia, after endoscopy procedures. The adoption of test strips is increasing for the effective measurement of the minimum effective concentration required for high-level disinfection, thereby providing faster disinfection reactions. In addition, they assist in the detection of residual proteins, carbohydrates, and hemoglobin on both flexible and rigid endoscopes, through the color comparison chart.

The automated endoscope reprocessors category will have the highest CAGR, of 9.8%, due to the rising number of endoscopic surgeries and the surging adoption of AERs in hospitals and ambulatory surgical centers. Moreover, companies are actively involved in launching innovative and advanced AERs in the market. In addition, the efforts of government organizations to support the adoption of AERs enhance the endoscope reprocessing market growth.

The products analyzed in this report are:

• High-Level Disinfectants & Test Strips (Largest Category)
• Detergents & Wipes
• Automated Endoscope Reprocessors (Fastest-Growing Category)
• Endoscope Drying, Storage, & Transport Systems
• Endoscope Tracking Solutions

Type Analysis

The flexible category held the larger market share, of 70%, in 2024, and it will have the higher CAGR, of 9.9%, due to the rising incidence of GI diseases, thus leading to a rise in the number of hospital visits. For instance, around 40 million patients suffering from digestive system disorders visit physicians' offices in the U.S. each year. Flexible endoscopes' complex design featuring multiple narrow channels, articulating tips, and delicate components creates unique reprocessing challenges that drive demand for specialized equipment and consumables. The prevalence of gastrointestinal procedures, particularly colonoscopies and upper endoscopies, sustains this segment's leadership position as these instruments require meticulous cleaning and high-level disinfection between uses.

The types analyzed in this report are:

• Flexible (Larger and Faster-Growing Category)
  • Upper Gastrointestinal Endoscopes
  • Colonoscopes
  • Bronchoscopes
  • Sigmoidoscopes
  • Laryngoscopes
  • Duodenoscopes
  • Nasopharyngoscopes
  • Rhinoscopes
• Rigid
  • Laparoscopes
  • Ureteroscopes
  • Gynecology Endoscopes
  • Arthroscopes
  • Cystoscopes
  • Neuroendoscopes

End User Analysis

The hospitals category held the larger market share, of 70%, in 2024, and it will have the higher CAGR, of 9.8%, due to the rising number of endoscopy procedures, coupled with the increasing number of hospitals all over the world and the promulgation of funds and investments provided by government bodies. Hospital endoscopy departments process substantial procedural volumes across multiple specialties, necessitating robust reprocessing infrastructure capable of handling diverse endoscope types efficiently. The segment benefits from larger capital budgets enabling investment in advanced automated reprocessing systems, dedicated reprocessing rooms, and comprehensive quality assurance programs that ensure compliance with accreditation standards.

The end users analyzed in this report are:

• Hospitals (Larger and Faster-Growing Category)
• Ambulatory Surgical Centers & Clinics

Endoscope Reprocessing Market Geographical Analysis

North America Endoscope Reprocessing Market Size

North America held the largest market share, of 40%, in 2024, due to the rising frequency of technological advancements, surging geriatric population, increasing prevalence of chronic diseases, especially gastric disorders; presence of giant players, improving healthcare services, and increasing number of hospitals. Additionally, the demand for endoscopies is increasing among the elderly population as it is more prone to chronic diseases, such as cardiac disorders, cancer, blocked arteries, and gastroesophageal reflux disease (GERD). These diseases drive the demand for GI endoscopies and colonoscopies for their diagnosis. Furthermore, the rise in capital expenditure on healthcare infrastructure and the growth in the number of hospitals and imaging centers in North America drive this market.

The implementation of updated reprocessing guidelines by the FDA and CDC, combined with heightened awareness following publicized infection outbreaks, has catalyzed significant investments in advanced reprocessing technologies across North American healthcare facilities. Hospitals and ASCs increasingly adopt automated endoscope reprocessors featuring enhanced documentation capabilities to demonstrate regulatory compliance and mitigate liability risks. Additionally, the region witnesses growing adoption of supplemental reprocessing measures, including liquid chemical sterilization for high-risk endoscopes, reflecting a proactive approach to infection prevention that drives market expansion.

U.S. Endoscope Reprocessing Market Size

The U.S. is experiencing a demographic shift with the increase in the number of citizens aged 65 years and older. As stated by the U.S. Census Bureau, the 65 years and older age group's share in the total population is projected to rise to nearly 24% (98 million) by 2060 from 15% (52 million) in 2018. The American Hospital Association (AH) estimates the total number of hospitals associated with it at 6,093. In addition to its use in disease diagnosis and management, endoscopy plays an important role in clinical research. As per the National Cancer Institute, colorectal cancer is the fourth most prevalent in the country, with 154,270 new diagnoses expected in 2025.

Asia-Pacific Endoscope Reprocessing Market Size

Asia-Pacific will have the highest CAGR, of 10.7%, driven by rapidly expanding healthcare infrastructure, increasing disease burden, and growing awareness of infection control standards. The region's growth trajectory reflects multiple converging factors, including rising healthcare expenditure, expansion of insurance coverage, and increasing adoption of Western healthcare practices emphasizing preventive screening and minimally invasive interventions.

China and India emerge as primary growth engines within Asia Pacific, with both countries witnessing substantial increases in endoscopic procedure volumes driven by rising incidence of gastrointestinal cancers, improving diagnostic capabilities, and expanding physician expertise. According to healthcare statistics, the prevalence of gastroesophageal reflux disease in Asian populations ranges from 2.5–17.0%, creating significant demand for diagnostic and therapeutic endoscopy. The region's market expansion is further supported by increasing regulatory focus on healthcare quality, prompting hospitals to upgrade reprocessing infrastructure to meet international standards and achieve accreditation from bodies such as Joint Commission International.

Japan Endoscope Reprocessing Market Size

Japan maintains a distinctive position within the region, characterized by advanced healthcare technology adoption and stringent quality standards that drive sophisticated reprocessing practices. The country's emphasis on precision and consistency in healthcare delivery translates to widespread adoption of automated reprocessing systems and comprehensive quality assurance protocols. Japanese healthcare facilities frequently align with international best practices from organizations including the World Health Organization and European Society of Gastrointestinal Endoscopy, elevating reprocessing standards beyond regional norms.

Colorectal cancer is highly prevalent in Japan, with an incidence of ~100 cases per 100,000 for colon and ~39 per 100,000 for rectal cancer in 2020 (~98,240 colon; ~49,485 rectal cases).

The Japanese market benefits from strong domestic medical device manufacturing capabilities, with companies like Olympus and Fujifilm developing innovative endoscope designs that facilitate effective reprocessing. Moreover, the integration of advanced technologies, including IoT-enabled tracking systems and real-time monitoring capabilities, reflects Japan's commitment to leveraging technology for enhanced patient safety. Japan's aging society, with one of the world's highest proportions of elderly citizens, ensures sustained demand for endoscopic procedures and associated reprocessing solutions.

The geographical breakdown of the market is as follows:

• North America (Largest Regional Market)
  • U.S. (Larger and Faster-Growing Country)
  • Canada
• Europe
  • Germany (Largest and Fastest-Growing Country)
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific (Fastest-Growing Regional Market)
  • China (Largest Country)
  • India (Fastest-Growing Country)
  • Japan
  • South Korea
  • Australia
  • Rest of APAC
• Latin America
  • Brazil (Largest Country)
  • Mexico (Fastest-Growing Country)
  • Rest of LATAM
• Middle East and Africa
  • Saudi Arabia (Largest and Fastest-Growing Country)
  • South Africa
  • U.A.E.
  • Rest of MEA

Endoscope Reprocessing Market Share

The market is moderately consolidated due to the presence of a few dominant players, high entry barriers such as stringent regulatory requirements and significant R&D investments, and strong relationships with healthcare providers that create switching barriers. Leading companies leverage comprehensive product portfolios spanning automated reprocessors, consumables, and service offerings to capture greater wallet share within customer accounts while creating switching barriers through integrated solutions. Market leaders maintain competitive advantages through continuous innovation, with recent product launches emphasizing enhanced automation, improved cycle times, and comprehensive data management capabilities.

Endoscope Reprocessing Market News

• In March 2025, Nanosonics CORIS automated cleaning system received the FDA’s de novo clearance for use to clean complex inner channels of flexible endoscopes and eliminate biofilm-associated risks.
• In June 2024, Olympus Corporation launched the ETD Endoscope Washer Disinfector series, available in Basic and Premium configurations, featuring enhanced water efficiency that reduces consumption by 25 liters per cycle while maintaining validated high-level disinfection efficacy across all endoscope channels.
• In March 2024, Cantel Medical Corp. launched a new automated endoscope reprocessor designed to enhance hygiene compliance.
• In November 2023, HOYA Corporations acquired full ownership of Wassenburg Medical B.V., integrating its comprehensive endoscope reprocessing systems with PENTAX Medical to further accelerate automation innovation in reprocessing technology.